Literature DB >> 25441584

Curcumin: a pleiotropic phytonutrient in diabetic complications.

Manish Kumar Jeenger1, Shweta Shrivastava1, Veera Ganesh Yerra1, V G M Naidu1, Sistla Ramakrishna2, Ashutosh Kumar3.   

Abstract

Curcumin is the major polyphenolic constituent of an indigenous herb, Curcuma longa, found to have a wide range of applications right from its kitchen use as a spicy ingredient to therapeutic and medicinal applications in various diseases. Curcumin has been identified to have a plethora of biologic and pharmacologic properties owing to its antioxidant and anti-inflammatory activities. This pleiotropic regulation of redox balance of cell and inflammation might be the basis of curcumin's beneficial activities in various pathologic conditions including diabetic complications. This review summarizes various in vitro, in vivo studies done on curcumin and its therapeutic utility in diabetic micro-vascular complications. This review also emphasizes the importance of curcumin in addition to the existing therapeutic modalities in diabetic complications.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Curcumin; Diabetic complications; Nephropathy; Neuropathy; Retinopathy

Mesh:

Substances:

Year:  2014        PMID: 25441584     DOI: 10.1016/j.nut.2014.06.015

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  6 in total

1.  Curcumin Inhibits Neuronal Loss in the Retina and Elevates Ca²⁺/Calmodulin-Dependent Protein Kinase II Activity in Diabetic Rats.

Authors:  Jun Li; Peipei Wang; Yanxia Zhu; Zhen Chen; Tianyan Shi; Wensheng Lei; Songping Yu
Journal:  J Ocul Pharmacol Ther       Date:  2015-07-24       Impact factor: 2.671

2.  Effect of Curcumin on Glycemic Control in Patients with Type 2 Diabetes: A Systematic Review of Randomized Clinical Trials.

Authors:  Atena Mahdavi; Sajjad Moradi; Gholamreza Askari; Bijan Iraj; Thozhukat Sathyapalan; Paul C Guest; Mohammad Bagherniya; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Novel strategies to prevent the development of multidrug resistance (MDR) in cancer.

Authors:  Jinglu Wang; Nicole Seebacher; Huirong Shi; Quancheng Kan; Zhenfeng Duan
Journal:  Oncotarget       Date:  2017-07-12

4.  Curcumin Improves Palmitate-Induced Insulin Resistance in Human Umbilical Vein Endothelial Cells by Maintaining Proteostasis in Endoplasmic Reticulum.

Authors:  Mao Ye; Hong Qiu; Yingkang Cao; Min Zhang; Yan Mi; Jing Yu; Changhua Wang
Journal:  Front Pharmacol       Date:  2017-03-21       Impact factor: 5.810

Review 5.  Molecular Mechanisms Underlying Curcumin-Mediated Therapeutic Effects in Type 2 Diabetes and Cancer.

Authors:  Marzena Wojcik; Michal Krawczyk; Pawel Wojcik; Katarzyna Cypryk; Lucyna Alicja Wozniak
Journal:  Oxid Med Cell Longev       Date:  2018-03-20       Impact factor: 6.543

6.  Curcumin alleviates diabetic nephropathy via inhibiting podocyte mesenchymal transdifferentiation and inducing autophagy in rats and MPC5 cells.

Authors:  Qiudi Tu; Yiwen Li; Juan Jin; Xinxin Jiang; Yan Ren; Qiang He
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.